Pathomorpological research of vaginal suppositories “klimedeks” in rats with the irrytative vaginitis
DOI:
https://doi.org/10.24959/ubphj.16.87Keywords:
experimental vaginitis, postmortem study, vaginal suppositories, ratsAbstract
Vaginitis is one of the most common reasons of women during calls to the gynecologist. The best method of their treatment is vaginal suppositories that contain antibacterial and anti-inflammatory components. We have studied
vaginal suppositories “Klimedeks” in female-rats with experimental vaginitis caused by irritants mixture of a gum turpentine and dimethylsulfoxide. Treatment of vaginitis was 8 days. At 5th and 8th days animals were taken out
of the experiment by method of euthanasia and researched vaginal mucosa by histologically. Vaginal suppositories “Klimedeks” at the fifth day of the experiment positively impact on the mucosa of the vagina in 87.5 % female rats of the animals had no signs of damage and inflammation of the lining of the vagina and superior comparator vaginal tablets “Mikozhynaks” for therapeutic effect. On the eighth day of the experiment, 100 % structural and functional state of animals mucous membrane of the vagina fully recovered. Placebo did no positive impact on the vagina of rats.
References
Верещако Г. В., Лазарева Н. В. Опыт лечения неспецифических вульвовагинитов у женщин старшей возрастной группы. Укр. мед. часопис online. 2010;1(75),I-II: Режим доступа: http://www.umj.com.ua/article/2980/opyt-lecheniya-nespecificheskix-vulvovaginitov-u-zhenshhin-starshej-vozrastnoj-gruppy
Hainer B. L., Gibson M. V. Vaginitis: diagnosis and treatment. Am. Fam. Physician. 2011;83(7):807-815.
Pirotta M. V., Gunn J. M., Chondros P. «Not thrush again!» Women’s experience of post antibiotic vulvovaginitis. Med J Aust. 2003;179(1):43-46.
Sobel J. D. Vulvovaginitis in healthy women. Compr Ther. 1999;25(6-7): 335-346.
Subramaniam A., Kumar R., Cliver S. P., Zhi D., Szychowski J. M., Abramovici A., Biggio J. R., Lefkowitz E. J., Morrow C., Edwards R. K. Vaginal Microbiota in Pregnancy: Evaluation Based on Vaginal Flora, Birth Outcome, and Race. Am J Perinatol. 2016;33(4):401-408.
Eckert L. O., Hawes S. E., Stevens C. E., Koutsky L. A., Eschenbach D. A., Holmes K. K. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol.1998;92(5):757-765.
Nyirjesy P., Robinson J., Mathew L., Lev Sagie A., Reyes I., Culhane J. F. Alternative therapies in women with chronic vaginitis. Obstet Gynecol. 2011:117(4):856-861.
Palma F., Volpe A., Villa P., Cagnacci A. and as the writing group of the Agatastudy. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas. 2016:83:40-44.
Tersigni C., Di Simone N., Tempestilli E., Cianfrini F., Russo R., Moruzzi M. C., Amar I. D., Fiorelli A., Scambia G., Villa P. Non hormonal treatment of vulvovaginal atrophy related symptoms in post-menopausal women. J Obstet Gynaecol. 2015:35(8):835-838.
Пат. 61038 UA МГЖ А 61 К 9/02 А 61 К 31/00 А 61К 36/72 А 61 Р 15/02. Засіб у формі песаріїв для лікування інфекційно-запальних гінекологічних захворювань / Степанова К. О., Должикова О. В., Малоштан Л. М., Левачкова Ю. В., Чушенко В. М., Ярних Т. Г. Опубл. 11.07.2011, Бюл. № 13.
European conventi on for the protection of vertebral animals used for experimental and other scientific purpose: Council of Europe 18.03.1986. Strasbourg, 1986. 52 р. 12. Пат. 95741 UA МПК (2006.01) А61К 31/565 А61К 31/197 А61К 9/02 А61Р 15/08 А61Р 15/
Фармацевтична композиція для лікування захворювань урогенітальних органів / Рудько А. Ю., Солнцева А. В., Усоєва Л. А., Моругіна Л. В. Опубл. 25.08.2011, Бюл. № 16.
Рыболовлев Ю. Р., Рыболовлев Р. С. Дозирование веществ для млекопитающих по константам биологической активности. Доклады АН СССР. 1979;247(6):1513-1516.
Меркулов Г. А. Курс патологогистологической техники. М.: Медиц., Ленингр. отд-ние, 1969. 424 с.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
